Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Ampio Pharmaceuticals (NY: AMPE )

1.769 USD +0.049 (+2.85%)
Streaming Delayed Price Updated: 10:16 AM EDT, Apr 23, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Ampio Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
Ampio Pharmaceuticals, Inc. to Report Fiscal 2021 First Quarter Financial Results and Provide Corporate Business Update
Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced it will host a... 
From PR Newswire
Research Shows Ampion™ Gene Regulation Mimics the Anti-Inflammatory Effects of Steroids, but without Adverse Effects
Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions for which there are limited... 
From PR Newswire
Interesting AMPE Put And Call Options For June 18th
Investors in Ampio Pharmaceuticals Inc (AMPE) saw new options become available today, for the June 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AMPE... 
Tags Stocks
From Market News Video
Ampio Pharmaceuticals' Study Shows Ampion Inhibits a Key Inflammatory Pathway in COVID-19 and Lupus Nephritis
Laboratory results suggest Ampion's suitability for addressing kidney diseases and provides further evidence it is a platform biologic for treatment of inflammatory and autoimmune diseases. 
From PR Newswire
Ampio Pharmaceuticals is Building on its Progress in Tackling Osteoarthritis and COVID-19 Respiratory Issues
Ampio Pharmaceuticals (NYSE American: AMPE), a clinical stage biopharmaceutical company focused on the advancement of immunology-based ... 
Tags Penny Stocks Biotech General
From Benzinga
Ampio Pharmaceuticals to Present at the International Society for Aerosols in Medicine (ISAM) 23rd International Congress
The company's findings will be showcased to over 400 clinicians, respiratory health and critical care professionals, aerosol scientists, engineers, product development and regulatory experts 
From PR Newswire
First Week of AMPE May 21st Options Trading
Investors in Ampio Pharmaceuticals Inc (AMPE) saw new options begin trading this week, for the May 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AMPE... 
Tags Stocks
From Market News Video
Ampio Pharmaceuticals to Present at Benzinga Biotech Small Cap Conference
Ampio Pharmaceuticals (NYSE American: AMPE), a clinical stage biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced... 
From PR Newswire
Ampio Pharmaceuticals Details Early Positive Results for Inhaled Ampion in COVID-19 Respiratory Distress
Also provides updates on (i) forthcoming Phase I clinical trial utilizing inhaled Ampion to treat "long hauler" COVID-19 symptoms and (ii) research into indications in kidney and pediatric diseases. 
From PR Newswire
Ampio Pharmaceuticals to Participate in the 33rd Annual Virtual ROTH Conference on March 15-17, 2021
Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced that it has been... 
From PR Newswire
Roth Capital Partners 33rd Annual Conference to be held Virtually March 15-17, 2021
Premier Small-Cap Growth Conference to host more than 400 public and private companies 
From GlobeNewswire News Releases
82 Biggest Movers From Yesterday
Gainers Five Prime Therapeutics, Inc. (NASDAQ: FPRX) shares surged 78.7% to close at $38.00 on Thursday after Amgen announced ... 
Tags ACY MRVL WTI
From Benzinga
Why Ampio Pharmaceuticals Stock Is Jumping Today
Investors liked what they heard in the company's Q4 update. 
Tags AMPE Market News
From Motley Fool
45 Stocks Moving In Thursday's Mid-Day Session
Gainers Five Prime Therapeutics, Inc. (NASDAQ: FPRX) shares jumped 78% to $37.85 after Amgen announced plans to acquire the ... 
Tags SLGG Penny Stocks Top Gainers
From Benzinga
Best Penny Stocks To Watch Right Now As Markets Attempt To Rebound
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
The Daily Biotech Pulse: FDA Nod For Pfizer, Kiniksa Rises On Commercialization Pact With Regeneron, Bio-Techne To Buy Diagnostic Company
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags FULC RNLX LLY
From Benzinga
33 Stocks Moving in Thursday's Pre-Market Session
Gainers Allied Esports Entertainment Inc. (NASDAQ: AESE) shares rose 56.8% to $3.92 in pre-market trading. In January, Allied ... 
Tags Small Cap Pre/Market Movers Pre/Market Outlook
From Benzinga
Ampio Pharmaceuticals (AMPE) Q4 2020 Earnings Call Transcript
AMPE earnings call for the period ending December 31, 2020. 
Tags Market News AMPE
From Motley Fool
Ampio Pharmaceuticals, Inc. Reports Fourth Quarter 2020 Financial Results and Provides Business Update
FDA recommends we conduct a randomized, double-blinded, placebo-controlled Phase II for Intravenous (IV) and Inhaled Ampion to allow consideration of EUA treatment of COVID-19 patients 
From PR Newswire
Ampio Pharmaceuticals to Present at the H.C. Wainwright Global Life Sciences Conference
Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced that... 
From PR Newswire
The Daily Biotech Pulse: KemPharm ADHD Drug Gets The Nod, MediciNova Shelves Vaccine Study
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Earnings LHDX OVID
From Benzinga
Thinking about buying stock in Powerbridge Technologies, BioCryst Pharma, Oramed Pharma, Ampio Pharma, or Plus Therapeutics?
InvestorsObserver issues critical PriceWatch Alerts for PBTS, BCRX, ORMP, AMPE, and PSTV. 
From PR Newswire
Penny Stocks To Buy For Under $3 This Week, Are They On Your List?
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Ampio Pharmaceuticals, Inc. to Report Annual 2020 Financial Results and Provide Corporate Business Update
Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced it will host a... 
From PR Newswire
Ampio Brings New Hospitals Online in Trial for Inhalation Treatment of COVID-19 with Ampion
Additional study sites will accelerate patient enrollment. 
From PR Newswire
Thinking about buying stock in Ampio Pharmaceuticals, Motus GI, Phio Pharmaceuticals, Novan, or Oncolytics Biotech?
InvestorsObserver issues critical PriceWatch Alerts for AMPE, MOTS, PHIO, NOVN, and ONCY. 
From PR Newswire
43 Stocks Moving In Tuesday's Mid-Day Session
Gainers Socket Mobile, Inc. (NASDAQ: SCKT) shares shot up 191.67% to $9.45, driven by heavy volumes after the company unveiled ... 
Tags DPW LDI GSAT
From Benzinga
Ampio Pharmaceuticals, Inc. to Present at Upcoming Investor Conference
Corporate Presentation to be Webcast on February 17, 2021 
From PR Newswire
30 Stocks Moving In Friday's Mid-Day Session
Gainers Greenvision Acquisition Corp. (NASDAQ: GRNVU) rose 5.76% to $13.78. Rigrodsky Law, P.A. announced that it is ... 
Tags Benzinga Movers NUS
From Benzinga
Ampio Announces Early Positive Data in Phase 1 Trial of Inhaled Ampion in COVID-19 Respiratory Distress
- Subjects who received Ampion treatment required less oxygen than standard of care alone. 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.